Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used

  • Brief Communication
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification, and response assessment of multiple myeloma. Leukemia. 2009;23:3–9.

    Article  PubMed  CAS  Google Scholar 

  2. Rajkumar SV, Kyle RA, Therneau TM, Melton LJ 3rd, Bradwell AR, Clark RJ, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood. 2005;106:812–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Vermeersch P, Vercammen M, Holvoet A, Vande Broek I, Delforge M, Bossuyt X. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders. Clin Chim Acta. 2009;410:54–8.

    Article  PubMed  CAS  Google Scholar 

  4. Palladini G, Russo P, Bosoni T, Verga L, Sarais G, Lavatelli F, et al. Identification of amyloidogenic light chains requires the combination of serum-free light chains and with immunofixation of serum and urine. Clin Chem. 2009;55:499–504.

    Article  PubMed  CAS  Google Scholar 

  5. Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol. 2012;30:4541–9.

    Article  PubMed  CAS  Google Scholar 

  6. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem. 2001;47:673–80.

    PubMed  CAS  Google Scholar 

  7. te Velthuis H, Knop I, Stam P, et al. N Latex FLC – new monoclonal high-performance assays for the determination of free light chain kappa and lambda. Clin Chem Lab Med. 2011;49:1323–32.

    Article  CAS  Google Scholar 

  8. Carr-Smith HD, Jenner EL, Evans JAR, Harding SJ. Analytical issues of serum free light chain assays and the relative performance of polyclonal and monoclonal based reagents. Clin Chem Lab Med. 2016;54:997–1003.

    Article  PubMed  CAS  Google Scholar 

  9. Palladini G, Jaccard A, Milani P, et al. Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays. Clin Chem Lab Med. 2017;55:1734–43.

    Article  PubMed  CAS  Google Scholar 

  10. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet. 2014;15:e538–48.

    Article  PubMed  Google Scholar 

  11. Larsen JT, Kumar SK, Dispenzieri A, Kyle RA, Katzmann JA, Rajkumar SV Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma. Leukemia. 2013;27:941–6

Download references

Acknowledgements

We thank Siemens and The Binding site for providing the reagents and for performing the assays. We thank Oscar Berlanga and Stephen Harding (both from the Binding Site) and Carola Wagner (from Siemens) for helpful discussions.

Author contribution

XB and MV designed the study and wrote the paper. XB, MV, MR, and DD analyzed the data. MD, KF, and BS take care of the patients with multiple myeloma and revised the manuscript. KP discussed the data and critically reviewed the study and the manuscript.

Author information

Author notes

  1. Martine Vercammen

    Present address: Department of Laboratory Medicine, AZ Sint-Jan, Brugge, Belgium

Authors and Affiliations

  1. Laboratory Medicine, Immunology, University Hospitals Leuven, Leuven, Belgium

    Xavier Bossuyt, Martin Reynders & Koen Poesen

  2. Department of Microbiology and Immunology, Experimental Laboratory Immunology, Catholic University of Leuven, Leuven, Belgium

    Xavier Bossuyt & Doreen Dillaerts

  3. Department of Hematology, University Hospitals Leuven, Leuven, Belgium

    Michel Delforge

  4. Department of Nephrology, University Hospitals Leuven, Leuven, Belgium

    Ben Sprangers

  5. Department of Hematology, University Hospital VUB, Brussels, Belgium

    Karel Fostier

  6. Department of Neurosciences, Laboratory for Molecular Neurobiomarker Research, KU Leuven, Leuven, Belgium

    Koen Poesen

  7. Laboratory of Hematology, Universitair Ziekenhuis Brussel VUB, Brussels, Belgium

    Martine Vercammen

Authors
  1. Xavier Bossuyt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michel Delforge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Reynders
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Doreen Dillaerts
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ben Sprangers
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Karel Fostier
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Koen Poesen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Martine Vercammen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xavier Bossuyt.

Ethics declarations

Conflict of interest

MV, KP, and XB received travel fees from The Binding Site. BS received research support from The Binding Site. The remaining authors declare no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bossuyt, X., Delforge, M., Reynders, M. et al. Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used. Leukemia 32, 1815–1818 (2018). https://doi.org/10.1038/s41375-018-0041-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41375-018-0041-0

  • Springer Nature Limited

This article is cited by

Search

Navigation